Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
Biogen’s Aduhelm Competitors Boosted By Final CMS Coverage Decision
Eisai, Roche, Lilly Will Have Efficacy Data Much Sooner
Apr 10 2022
•
By
Mandy Jackson
Medicare coverage of Aduhelm remains restricted to Alzheimer's patients in clinical trials • Source: Alamy
More from Drug Pricing
More from Scrip